Know Cancer

or
forgot password

National Evaluation of the Adherence to Recommendations of VTE Treatment in Cancer Patients


N/A
18 Years
N/A
Open (Enrolling)
Both
Neoplasms, Venous Thromboembolism

Thank you

Trial Information

National Evaluation of the Adherence to Recommendations of VTE Treatment in Cancer Patients


Inclusion Criteria:



All patients with cancer present in the clinic, hospital, out patients diagnosed with a
VTE during the 6 previous months. VTE can be symptomatic or asymptomatic, can be located
close to a central line, and of any type (DVT, PE, SVT)

Exclusion Criteria:

- Patient already included in a trial studying antithrombotic therapy

- Patient refusing the study

- Patient under 18 and/or not competent to give informed consent

Type of Study:

Observational

Study Design:

Observational Model: Cohort, Time Perspective: Prospective

Outcome Measure:

Evaluation of the adherence to recommendations of VTE treatment in cancer patients

Outcome Description:

Proportion of patients treated for evolutive VTE according to international recommandations Patients could be hospitalised or could be out patient

Outcome Time Frame:

At baseline (J0)

Safety Issue:

No

Principal Investigator

Marie-Antoinette SEVESTRE, MD

Investigator Role:

Principal Investigator

Investigator Affiliation:

CHU d'Amiens

Authority:

France: Comité consultatif sur le traitement de l'information en matière de recherche dans le domaine de la santé

Study ID:

Version N°2.0 du 21/03/2011

NCT ID:

NCT01362933

Start Date:

May 2011

Completion Date:

July 2011

Related Keywords:

  • Neoplasms
  • Venous Thromboembolism
  • PE
  • DVT
  • SVT
  • LMWH
  • VKA
  • international Venous Thromboembolism Recommendations
  • Neoplasms
  • Thromboembolism
  • Venous Thromboembolism
  • Venous Thrombosis

Name

Location